PUBLICATION

Comparative Proteome Research in a Zebrafish Model for Vanishing White Matter Disease

Authors
Kim, D., Lee, Y.R., Choi, T.I., Kim, S.H., Kang, H.C., Kim, C.H., Lee, S.
ID
ZDB-PUB-210407-16
Date
2021
Source
International Journal of Molecular Sciences   22(5): (Journal)
Registered Authors
Kim, Cheol-Hee
Keywords
EIF2B, SLC1A4, Vanishing White Matter disease, comparative proteomics
MeSH Terms
  • Amino Acid Transport System ASC/genetics
  • Amino Acid Transport System ASC/metabolism*
  • Animals
  • Animals, Genetically Modified
  • Disease Models, Animal
  • Eukaryotic Initiation Factor-2B/deficiency
  • Eukaryotic Initiation Factor-2B/metabolism
  • Humans
  • Leukoencephalopathies/genetics
  • Leukoencephalopathies/metabolism*
  • Leukoencephalopathies/pathology
  • Proteome/genetics
  • Proteome/metabolism*
  • Proteomics
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Zebrafish Proteins/genetics
  • Zebrafish Proteins/metabolism*
(all 18)
PubMed
33800130 Full text @ Int. J. Mol. Sci.
Abstract
Vanishing white matter (VWM) disease is a genetic leukodystrophy leading to severe neurological disease and early death. VWM is caused by bi-allelic mutations in any of the five genes encoding the subunits of the eukaryotic translation factor 2B (EIF2B). Previous studies have attempted to investigate the molecular mechanism of VWN by constructing models for each subunit of EIF2B that causes VWM disease. The underlying molecular mechanisms of the way in which mutations in EIF2B3 result in VWM are largely unknown. Based on our recent results, we generated an eif2b3 knockout (eif2b3-/-) zebrafish model and performed quantitative proteomic analysis between the wild-type (WT) and eif2b3-/- zebrafish, and identified 25 differentially expressed proteins. Four proteins were significantly upregulated, and 21 proteins were significantly downregulated in eif2b3-/- zebrafish compared to WT. Lon protease and the neutral amino acid transporter SLC1A4 were significantly increased in eif2b3-/- zebrafish, and crystallin proteins were significantly decreased. The differential expression of proteins was confirmed by the evaluation of mRNA levels in eif2b3-/- zebrafish, using whole-mount in situ hybridization analysis. This study identified proteins which candidates as key regulators of the progression of VWN disease, using quantitative proteomic analysis in the first EIF2B3 animal model of VWN disease.
Genes / Markers
Marker Marker Type Name
abatGENE4-aminobutyrate aminotransferase
ass1GENEargininosuccinate synthase 1
atf4aGENEactivating transcription factor 4a
atf6GENEactivating transcription factor 6
cadGENEcarbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
crybb1GENEcrystallin, beta B1
dhtkd1GENEdehydrogenase E1 and transketolase domain containing 1
eif2b3GENEeukaryotic translation initiation factor 2B, subunit 3 gamma
lonp1GENElon peptidase 1, mitochondrial
mbpaGENEmyelin basic protein a
1 - 10 of 16
Show
Figures
Figure Gallery (4 images)
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Allele Construct Type Affected Genomic Region
ck5TgTransgenic Insertion
    ck156a
      Small Deletion
      1 - 2 of 2
      Show
      Human Disease / Model
      1 - 1 of 1
      Show
      Sequence Targeting Reagents
      No data available
      Fish
      Antibodies
      No data available
      Orthology
      Engineered Foreign Genes
      Marker Marker Type Name
      GFPEFGGFP
      1 - 1 of 1
      Show
      Mapping